DJO expands foot and ankle surgery portfolio with acquisition of Trilliant Surgical

DJO, a leading provider of medical technologies based in Texas, has strategically enhanced its presence in the foot and ankle surgery market with the acquisition of Trilliant Surgical, a prominent provider of orthopedic foot and ankle implants. The acquisition, completed in January 2021 for an undisclosed sum, marks another significant step in DJO’s expansion following its acquisition by Colfax in 2018 for $3.15 billion.

Strategic Expansion in Orthopedics

This acquisition is a part of DJO’s broader strategy to dominate the foot and ankle surgical sector. It follows the successful integration of the Scandinavian Total Ankle Replacement (STAR) system acquired in 2020, further bolstering DJO’s capabilities in this specialized field. Trilliant Surgical, known for its comprehensive portfolio of small bone implant systems, has been at the forefront of designing and distributing innovative solutions for foot and ankle surgeons since its inception in 2007.

Brady Shirley, CEO of DJO, emphasized the strategic fit of the acquisition, stating, “Trilliant’s market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.”

Product Innovations and Market Impact

Houston-based Trilliant Surgical brings over 15 product lines to DJO, covering a range of procedures from forefoot, midfoot, rearfoot, to ankle surgeries. One of its notable offerings, the Arsenal Foot Plating System, is a titanium alloy plating system designed for a variety of surgical needs including fusions, osteotomies, and fractures, showcasing the company’s commitment to innovation and quality.

Jon Olson, CEO of Trilliant Surgical, expressed enthusiasm about joining DJO: “As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgical’s positive patient impact globally. DJO’s unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliant’s ability to grow, innovate and improve patient outcomes.”

Future Prospects and Industry Implications

The integration of Trilliant Surgical into DJO’s operations is expected to not only enhance DJO’s product offerings but also strengthen its market position in the rapidly growing orthopedic segment. This move is indicative of DJO’s aggressive expansion strategy and its commitment to providing comprehensive solutions across the spectrum of orthopedic care.

Experts in the medical technology field view this acquisition as a tactical move by DJO to consolidate its leadership in the orthopedics market, especially in the lucrative foot and ankle sector, which continues to demand high-quality, innovative solutions.